A new study fulfills a central goal of post-genomic medicine, the treatment of inherited loss-of-function disorders not by correcting a genetic mutation but by augmenting the efficiency with which the nascent mutant gene product undergoes conformational maturation and is deployed to its site of action.
References
Choudhury, P., Liu, Y. & Sifers, R.N. News Physiol. Sci. 12, 162–166 (1997).
Tong Ong, D.S., Mu, T.-W., Palmer, A.E. & Kelly, J.W. Nat. Chem. Biol. 6, 424–432 (2010).
Sawkar, A.R., D'Haeze, W. & Kelly, J.W. Cell. Mol. Life Sci. 63, 1179–1192 (2006).
Hutt, D.M., Powers, E.T. & Balch, W.E. FEBS Lett. 583, 2639–2646 (2009).
Powers, E.T., Morimoto, R.I., Dillin, A., Kelly, J.W. & Balch, W.E. Annu. Rev. Biochem. 78, 959–991 (2009).
Mu, T.-W. et al. Cell 134, 769–781 (2008).
Mu, T.-W., Fowler, D.M. & Kelly, J.W. PLoS Biol. 6, e26 (2008).
Cabral, C.M., Liu, Y. & Sifers, R.N. Trends Biochem. Sci. 26, 619–624 (2001).
Ellgaard, L., Molinari, M. & Helenius, A. Science 286, 1882–1888 (1999).
Wu, Y., Swulius, M.T., Moremen, K.W. & Sifers, R.N. Proc. Natl. Acad. Sci. USA 100, 8229–8234 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sifers, R. Manipulating proteostasis. Nat Chem Biol 6, 400–401 (2010). https://doi.org/10.1038/nchembio.374
Issue Date:
DOI: https://doi.org/10.1038/nchembio.374
- Springer Nature America, Inc.